Sort
39,280 grants matching “leukemia”
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
$544,924Boris Reizis · New York University School Of Medicine · R37 · FY2022 · AI
Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death
$544,883Dean W Felsher · Stanford University · R01 · FY2012 · CA
Effect of inflammation on JAK2 mutant evolution in the hematopoietic system: mathematical models and experiments
$544,880Angela Goffredo Fleischman · University Of California-Irvine · R37 · FY2022 · CA
Expression profiling of renal cell carcinoma utilizing tissue from CALGB 90206
$544,855Hyung L Kim · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA
Molecular screening: MALDI-TOF scanning of peptides (RMI)
$544,776Stephen J. Kron · University Of Chicago · R01 · FY2007 · HG
Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia
$544,739Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia
$544,735Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Targeting the Epigenome for Lung Cancer Therapy
$544,723David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Targeting Tumors with NF1 Loss
$544,581Yolanda Sanchez · Dartmouth College · R01 · FY2017 · NS
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
$544,535Jennifer A Philips · Washington University · R01 · FY2019 · AI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
$544,535Jennifer A Philips · Washington University · R01 · FY2021 · AI
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
$544,535Jennifer A Philips · Washington University · R01 · FY2020 · AI
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu
$544,480Harlan S. Robins · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
Decoding the metabolic routes of purine nucleotides in cancer - Resubmission - 1
$544,478Gerta N/a Hoxhaj · Ut Southwestern Medical Center · R01 · FY2025 · CA
Trpm2: A novel target in Onco-cardiology
$544,434Joseph Y Cheung · Temple Univ Of The Commonwealth · R01 · FY2019 · HL
Role of Runx1 in Pathologic Ocular Angiogenesis
$544,408Leo A Kim · Schepens Eye Research Institute · R01 · FY2020 · EY
Artificial, Humanized Stem Cell Niches
$544,399Biju Parekkadan · Rutgers, The State Univ Of N.J. · R01 · FY2019 · EB
Targeting medium chain fatty acid metabolism for the treatment of chronic Graft-versus-Host Disease
$544,260Hung Nguyen · University Of Central Florida · R01 · FY2025 · HL
Development of ASH1L inhibitors for acute leukemia
$544,236Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy
$544,131Weiqiang Chen · New York University · R01 · FY2020 · CA
Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia
$544,106Richard A. Van Etten · University Of California-Irvine · R01 · FY2016 · CA
Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia
$544,106Richard A. Van Etten · University Of California-Irvine · R01 · FY2018 · CA
Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia
$544,106Richard A. Van Etten · University Of California-Irvine · R01 · FY2017 · CA
Tissue Core
$544,088Laura Z Rassenti · University Of California, San Diego · P01 · FY2015 · CA
MATH INTERVENTION FOR CHILDREN WITH LEUKEMIA
$544,075University Of Arizona · R01 · FY2002 · NR